TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · major macro event coming up
LXRX

Lexicon Pharmaceuticals Inc

Healthcare · Biotechnology

1.90$ -1.1% vs. previous close Closing price · As of: Sep 29, 2026

Ownership

Ownership Structure

Who owns Lexicon Pharmaceuticals Inc (LXRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 49.2% of the shares are freely tradable; institutional investors hold 82.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 82.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 49.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 12.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 445Mio.

Largest Shareholders

Institutions

Institutions LXRX
Name Stake (%) Shares Change (%) Date
Artal Group S A 39.36 175,156,062 +13.2 06/30/2026
FMR Inc 10.13 45,056,338 +19.1 03/31/2026
Siren, L.L.C. 9.96 44,303,518 +13.8 03/31/2026
Sessa Capital, L.P 4.03 17,912,961 +497.1 03/31/2026
Vanguard Capital Management, LLC 2.14 9,519,167 +0.0 03/31/2026
Point72 Asset Management, L.P. 1.76 7,814,606 +2,651.4 03/31/2026

Funds

Funds LXRX
Name Stake (%) Shares Change (%) Date
Fidelity Growth Company Fund 4.28 19,047,437 +10.4 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 1.59 7,083,651 +0.0 08/31/2026
iShares Russell 2000 ETF 1.40 6,227,913 -0.6 08/31/2026
Fidelity Growth Company K6 1.26 5,597,869 +10.1 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?